On the recordSeptember 19, 2016
I'm not certain that the current FDA structure could provide that stability.
Source
congress.govI'm not certain that the current FDA structure could provide that stability.
Hatch expresses doubt about the FDA's ability to ensure stability in healthcare testing.
Share
More from Orrin Hatch
Having a confirmed Commissioner, and sustained leadership, will benefit the Social Security Administration.
Those backlogs at the Social Security Administration are unacceptable to many, if not most, of us here in the Senate.
Understanding what is happening in field and regional offices is critical in the role of executive leader of the agency.
It is disappointing the ranking member feels a need to question a statement that I made during the hearing.